ChemoMetec

CHEMM Nasdaq Copenhagen ISIN DK0060055861 LEI 213800533NBKECGONO68
Follow ChemoMetec Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2026 DKK · IFRS
Revenue, last year DKK 511.1M +3.1% vs prior year
Net income DKK 201.8M +8.3% vs prior year
EPS, diluted -
Operating cash flow DKK 210.4M +1.4% vs prior year
Revenue by fiscal year
DKK 495.6M
DKK 511.1M
FY25 FY26

Source: ESEF annual reports · latest filing